Diabetes area participation analysis: a review of companies and targets described in the 2008 - 2010 patent literature.
about
MicroRNAs as pharmacological targets in diabetesThe case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy3'-axial CH2 OH substitution on glucopyranose does not increase glycogen phosphorylase inhibitory potency. QM/MM-PBSA calculations suggest whyDesign novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approachGPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight.Action of molecular switches in GPCRs--theoretical and experimental studies.Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?The Hypothalamic-Pituitary-Adrenal Axis, Obesity, and Chronic Stress Exposure: Sleep and the HPA Axis in ObesitySterculic Oil, a Natural SCD1 Inhibitor, Improves Glucose Tolerance in Obese ob/ob MiceA survey of small molecule glucagon receptor antagonists from recent patents (2006 - 2010).Recent discovery of plant-derived anti-diabetic natural products.Latest research and development trends in non-insulin anti-diabetics.Pharmacodynamic model of sodium-glucose transporter 2 (SGLT2) inhibition: implications for quantitative translational pharmacology.Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.Building structure-activity insights through patent mining.An Integrated Computational Approach for Plant-Based Protein Tyrosine Phosphatase Non-Receptor Type 1 Inhibitors.Identification of novel PPARα/γ dual agonists by virtual screening, ADMET prediction and molecular dynamics simulations.Diabetes area patent participation analysis - part II: years 2011-2016.Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats.
P2860
Q26824024-C23AA832-7681-427B-A5F0-4A88D4B23B81Q26865958-EE300366-0A28-42CA-84D3-2E288FFB6664Q27676986-DA84210B-0675-452A-8968-366EE6CE44B1Q28484141-06E44F7A-B769-4D2B-8D79-9C6A7702A236Q33630584-B4E4D939-437B-4AE4-97EA-79E868BC6D2BQ34251407-5116B994-004E-4CD2-8390-9902C80A57E1Q36174164-1BB95F5B-4071-40B1-B489-A5C5D024CDA0Q36399676-87C9EACC-E849-460B-8EFC-9F8C054658C8Q36417959-6A70655F-09DD-47FB-A47F-2035C4ABED73Q37884060-DFFDE541-015A-446A-AB21-22D1EEC772E2Q38001579-804F9288-2250-422F-ACDF-2EA743537C07Q38080471-92754F3F-BB63-4B53-8BD4-BA08BA833A01Q39636097-748C0D0B-86F3-4D1B-BE63-370C567844E1Q39771912-AA918C94-E5C4-4F1D-9586-4CA415B98B66Q46002723-B2D95D1E-8D71-4922-9BE5-14D424760B6AQ47111998-447621BE-1F31-4BD9-A97D-C0101949A1FAQ47739754-F262997B-0E68-408C-8C77-51D1CCF2ED80Q47838652-3A394A88-3C21-4631-975D-8173B58B84B0Q51344866-6C6EEC7B-735A-406C-862E-C55CDA0BF79D
P2860
Diabetes area participation analysis: a review of companies and targets described in the 2008 - 2010 patent literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diabetes area participation an ...... 2008 - 2010 patent literature.
@en
Diabetes area participation an ...... 2008 - 2010 patent literature.
@nl
type
label
Diabetes area participation an ...... 2008 - 2010 patent literature.
@en
Diabetes area participation an ...... 2008 - 2010 patent literature.
@nl
prefLabel
Diabetes area participation an ...... 2008 - 2010 patent literature.
@en
Diabetes area participation an ...... 2008 - 2010 patent literature.
@nl
P2860
P1476
Diabetes area participation an ...... 2008 - 2010 patent literature.
@en
P2093
Bryan Goodwin
Philip A Carpino
P2860
P304
P356
10.1517/13543776.2010.533171
P407
P577
2010-12-01T00:00:00Z